Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection

Clinical trial NCT03866187 · TERMINATED

Trial details

NCT number: NCT03866187
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatitis B, Chronic

Start date: 2019-03-28
Primary completion: 2024-10-07
Enrollment: 236

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.